MedTrace Logo

Mindfulness During COVID-19

NCT04319445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2022-03-02

Study results available
· View outcomes & findings →

Summary

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.

Conditions

  • Migraine Disorders
  • Stress
  • Anxiety

Interventions

BEHAVIORAL

Mindfulness session(s)

The sessions will be hosted online using an online platform (such as through webex, private YouTube page, Facebook live, etc).

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Rebecca E Wells, MD, MPH · Wake Forest University Health Sciences

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-23
Primary Completion
2020-07-28
Completion
2020-07-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04319445 on ClinicalTrials.gov